双鹭药业 (002038)
Beijing SL Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameBeijing SL Pharmaceutical Co., Ltd.
Listing Date2004-09-09
Issue Price12RMB
Registered Capital10273510k RMB
Legal RepresentativeXu Mingbo
Registered Address4th Floor, Building 1, Bitongyuan, No. 69 Fushi Road, Haidian District, Beijing
IndustryChemical Pharmaceuticals
Main BusinessResearch, development, production, and operation of genetic engineering drugs, biochemical drugs, and chemical drugs.
Company ProfileBeijing SL Pharmaceutical Co., Ltd. was founded in 1994. It is a high-tech enterprise primarily engaged in the research, development, production, and operation of genetic engineering and biochemical drugs. It was the first company in Beijing to be listed on the SME Board and is a nationally recognized enterprise technology center.
The company has won one National Science and Technology Progress Second Prize and five Beijing Municipal Science and Technology Progress First, Second, and Third Prizes. It has independently applied for and received funding from the National "863" Program four times, with multiple projects receiving National Technology Innovation Fund support. It is the industrialization base for four National "863" Program achievements.
Stock Details
1. Key Indicators
- Total Shares(W): 102735.00
- Circulating A-Shares(W): 85191.35
- Earnings Per Share(RMB): 0.1373
- Net Assets Per Share(RMB): 5.5414
- Operating Revenue(W RMB): 45875.26
- Total Profit(W RMB): 15885.97
- Net Profit Attributable to Parent(W RMB): 14109.80
- Net Profit Growth Rate(%): 943.10
- Weighted Return on Equity(%): 2.5000
- Operating Cash Flow Per Share(RMB): -0.0060
- Undistributed Profit Per Share(RMB): 3.8645
- Capital Reserve Per Share(RMB): 0.0483
2. Main Business
The main business covers:
- Research, development, production and operation of genetic engineering and related drugs
3. Company Basic Information
- Company Name: Beijing SL Pharmaceutical Co., Ltd.
- Listing Date: 2004-09-09
- Industry: Pharmaceutical Manufacturing
- Address: Building 1, Bitong Garden, No. 69 Fushi Road, Haidian District, Beijing
- Website: www.slpharm.com.cn
- Company Profile: Approved by the Beijing Municipal Government Document Jing Zheng Han [2000] No. 86 "Notice on Agreeing to Change Beijing Shuanglu Pharmaceutical Co., Ltd. to Beijing Shuanglu Pharmaceutical Co., Ltd.", the issuer was changed from a limited liability company to a joint stock company on August 9, 2000.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Xinxiang Bailu Investment Group Co., Ltd. | Corporate | 15974.00 | 18.75 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 1212.13 | 1.42 |
| 3 | Southern China Securities CSI 1000 ETF | Fund | 658.87 | 0.77 |
| 4 | China Galaxy Securities Co., Ltd. - Stock Repurchase Special Account | Corporate | 589.87 | 0.69 |
| 5 | ChinaAMC CSI 1000 ETF | Fund | 390.85 | 0.46 |
5. Concept Sectors
- Venture Capital
- Biological Vaccine
- Private Hospital
- Gene Concept
- Smart Healthcare
- Industrial Hemp
- Medical Aesthetics
- NMN Concept
- Helicobacter Pylori
- Assisted Reproduction
- Hepatitis Concept
- Innovative Drugs
- Weight Loss Drugs
- Margin Trading
- CCTV 50
- SME 300
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information